MG-K10/Placebo

DRUG3 trials

Sponsors

Shanghai Mabgeek Biotech.Co.Ltd

Conditions

AsthmaAtopic DermatitisAtopic Dermatitis (AD)

Phase 2

A Study of MG-K10 Humanized Monoclonal Antibody Injection in Subjects With Atopic Dermatitis

CompletedNCT07103174

Shanghai Mabgeek Biotech.Co.LtdAtopic Dermatitis (AD)

Start: 2025-06-30End: 2026-04-29Updated: 2026-08-03

Phase 3

Study of MG-K10 Humanized Monoclonal Antibody Injection in Patients With Atopic Dermatitis

Shanghai Mabgeek Biotech.Co.LtdAtopic Dermatitis

Start: 2024-01-13End: 2025-12-12Target: 498Updated: 2024-02-23

Clinical Trial of MG-K10 in Stage III of Moderate to Severe Asthma

RecruitingNCT06837922

Shanghai Mabgeek Biotech.Co.LtdAsthma

Start: 2025-03-25End: 2028-01-15Target: 504Updated: 2025-04-17